IL1B and metabolic syndrome: Supplementation with CTE or BPL1® HT, both separately or in combination, prevented the MetS-induced overexpression of all proinflammatory markers, except for the gene expression of IL-1β, which was only significantly reduced by CTE, both alone or in combination with BPL1® HT (p < 0.001 for both).